Maresin Biosynthesis and Identification of Maresin 2, a New Anti-Inflammatory and Pro-Resolving Mediator from Human Macrophages
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Maresin Biosynthesis and Identification of Maresin 2, a New Anti-Inflammatory and Pro-Resolving Mediator from Human Macrophages
Authors
Keywords
Macrophages, Dendritic cells, Biosynthesis, Epoxides, Polymerase chain reaction, Inflammation, Monocytes, Phagocytosis
Journal
PLoS One
Volume 9, Issue 7, Pages e102362
Publisher
Public Library of Science (PLoS)
Online
2014-07-19
DOI
10.1371/journal.pone.0102362
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Maresin 1, a Proresolving Lipid Mediator Derived from Omega-3 Polyunsaturated Fatty Acids, Exerts Protective Actions in Murine Models of Colitis
- (2013) R. Marcon et al. JOURNAL OF IMMUNOLOGY
- Maresin-1 reduces the pro-inflammatory response of bronchial epithelial cells to organic dust
- (2013) Tara M Nordgren et al. RESPIRATORY RESEARCH
- Anti-Inflammatory Therapy in Chronic Disease: Challenges and Opportunities
- (2013) I. Tabas et al. SCIENCE
- Decisions About Dendritic Cells: Past, Present, and Future
- (2012) Ralph M. Steinman Annual Review of Immunology
- Expression and regulation of 12/15-lipoxygenases in human primary macrophages
- (2012) Sophia J.A. Wuest et al. ATHEROSCLEROSIS
- Lipid and lipid mediator profiling of human synovial fluid in rheumatoid arthritis patients by means of LC–MS/MS
- (2012) Martin Giera et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Specific lipid mediator signatures of human phagocytes: microparticles stimulate macrophage efferocytosis and pro-resolving mediators
- (2012) J. Dalli et al. BLOOD
- Macrophage proresolving mediator maresin 1 stimulates tissue regeneration and controls pain
- (2012) Charles N. Serhan et al. FASEB JOURNAL
- Self-Limited versus Delayed Resolution of Acute Inflammation: Temporal Regulation of Pro-Resolving Mediators and MicroRNA
- (2012) Gabrielle Fredman et al. Scientific Reports
- New Lives Given by Cell Death: Macrophage Differentiation Following Their Encounter with Apoptotic Leukocytes during the Resolution of Inflammation
- (2012) Amiram Ariel et al. Frontiers in Immunology
- Resolvins and Protectins in Inflammation Resolution
- (2011) Charles N. Serhan et al. CHEMICAL REVIEWS
- Pro-resolving actions and stereoselective biosynthesis of 18S E-series resolvins in human leukocytes and murine inflammation
- (2011) Sungwhan F. Oh et al. JOURNAL OF CLINICAL INVESTIGATION
- Mammalian soluble epoxide hydrolase is identical to liver hepoxilin hydrolase
- (2011) Annette Cronin et al. JOURNAL OF LIPID RESEARCH
- 14S,21R-dihydroxy-docosahexaenoic Acid Treatment Enhances Mesenchymal Stem Cell Amelioration of Renal Ischemia/Reperfusion Injury
- (2011) Haibin Tian et al. STEM CELLS AND DEVELOPMENT
- Alternative Activation of Macrophages: Mechanism and Functions
- (2010) Siamon Gordon et al. IMMUNITY
- 14S,21R-Dihydroxydocosahexaenoic Acid Remedies Impaired Healing and Mesenchymal Stem Cell Functions in Diabetic Wounds
- (2010) Haibin Tian et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The interaction of human natural killer cells with either unpolarized or polarized macrophages results in different functional outcomes
- (2010) F. Bellora et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Novel 14,21-dihydroxy-docosahexaenoic acids: structures, formation pathways, and enhancement of wound healing
- (2009) Yan Lu et al. JOURNAL OF LIPID RESEARCH
- Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions
- (2008) Charles N. Serhan et al. JOURNAL OF EXPERIMENTAL MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now